



A new study “Value Added Medicines: Time to Adjust the […]
Read moreBiosimilar medicines are transforming treatment by enabling better access to […]
Read morePharmaceutical industry leaders and key stakeholders from the generic, biosimilar […]
Read moreThe European Semester Country Specific Recommendations show that healthcare systems […]
Read moreSpeaking at the B20 Health Conference in Berlin, IFPMA Director-General […]
Read more